Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D41PKY
|
|||
| Drug Name |
BT-200
|
|||
| Indication | Von willebrand disease [ICD-11: 3B12; ICD-10: D68.0] | Phase 2 | [1] | |
| Company |
Band Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04677803) A Phase 2a Multiple Dose Basket Study of the Safety, Tolerability, and Pharmacologic Activity of BT200 in Patients With Hereditary Bleeding Disorders. U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Guardian Theapeutics | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.